Clinical Trials Logo

Lymphedema Primary clinical trials

View clinical trials related to Lymphedema Primary.

Filter by:
  • None
  • Page 1

NCT ID: NCT05485454 Completed - Lymphedema Clinical Trials

A Preference Study of Two Pneumatic Compression Devices for Patients With Lower Limb Lymphedema

Start date: June 11, 2022
Phase: N/A
Study type: Interventional

This study will aim to undertake a preference evaluation comparing the Aria Health Aria Freeā„¢ to a competitor's device by assessing overall satisfaction and preference of the devices individually and in comparison to one another. Twenty (20) subjects will be enrolled on this study at one study site in Houston, Texas.

NCT ID: NCT04252690 Completed - Lymphedema of Leg Clinical Trials

Physiological Study to Assess Mechanism of Action of MOBIDERM® in Lower-limb Lymphedema Patients

ACTIODERM
Start date: July 1, 2020
Phase: N/A
Study type: Interventional

MOBIDERM® demonstrated his interest through clinical studies on the treatment of lower or upper limb lymphedema (Mestre et al 2017; Quéré et al. 2014). This CE (Conformity European)-marking device is well established both in ambulatory and hospitalisation. Nevertheless, the mechanism of action of this device had never been confirmed and no experimental clinical studies had been performed. The hypothesis is that the MOBIDERM system creates a pressure differential between the contact zone underneath the foam cubes composing the system and their surrounding area, leading to a shear effect on the subcutaneous tissues treated. The aim of this study is thus to assess the mechanism of action of MOBIDERM on the lymphatic system by evaluating quantitative and qualitative effects of this medical device on lymphatic system, oedema volume and cutaneous parameters in 10 lymphoedema patients during their hospitalisation for reduction phase.

NCT ID: NCT04194619 Not yet recruiting - Marfan Syndrome Clinical Trials

Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study

COGRare5
Start date: January 2020
Phase:
Study type: Observational

There are no prospective studies of pregnancies for the diseases studied here in (Heredity Hemorrhagic Telangiectasia, Marfan syndrome, primary lower limb lymphedema, superficial arteriovenous malformations, and cerebro-spinal arteriovenous malformations) although complications of these can present life-threatening health problems for the mother and her baby. The purpose of this National prospective study is to obtain greater insight into obstetrical complications associated with rare maternal vascular genetic disorders in order to improve prevention and to reduce risk of death. In this context, experts and patient associations consider that there is a need to make real progress in the formulation of recommendations based on scientific data.